BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14.08.2023

Request for Letters of Interest (LOI) for NCI-ComboMATCH Laboratories

The National Cancer Institute has developed a successor precision medicine trial, NCI-ComboMATCH, to overcome drug resistance to single-agent therapy by developing genomically-directed targeted agent combinations.

Source: Federal Register — Health and Human ServicesOpen original release →